Evidence map›Paper›PMID 27122577›Full record

ArticleJournal of virology2016

NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.

Markus Kainulainen, Simone Lau, Charles E Samuel, Veit Hornung, Friedemann Weber

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. SKP1-CUL1-F-box: Key molecular targets affecting disease progression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  6. Review
  7. Article
  8. SCFBiomedicines · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Use of Human Macrophages to Study Bunyavirus NSs Functions.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Markus KainulainenInstitute for Virology, Philipps-Universität Marburg, Marburg, Germany.
Simone LauInstitute for Virology, Philipps-Universität Marburg, Marburg, Germany Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig-Universität Gießen, Giessen, Germany.
Charles E SamuelDepartment of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California, USA Biomolecular Sciences and Engineering Program, University of California, Santa Barbara, California, USA.
Veit HornungInstitute of Molecular Medicine, University Hospital, Universität Bonn, Bonn, Germany Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Friedemann WeberInstitute for Virology, Philipps-Universität Marburg, Marburg, Germany Institute for Virology, FB10-Veterinary Medicine, Justus-Liebig-Universität Gießen, Giessen, Germany friedemann.weber@vetmed.uni-giessen.de.ORCID 0000-0001-9737-337X
Philipps University of Marburg · DEUniversity Hospital Bonn · DEUniversity of California, Santa Barbara · US

Funding

INTERFERON ACTION AND PROTEIN PHOSPHORYLATIONR01AI020611 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E · 1985 to 2014
$3.4M
NIAID NIH HHS R01 AI020611
6 · The paper itself

Abstract

unlabelledRift Valley fever virus (RVFV, family Bunyaviridae, genus Phlebovirus) is a relevant pathogen of both humans and livestock in Africa. The nonstructural protein NSs is a major virulence factor known to suppress the type I interferon (IFN) response by inhibiting host cell transcription and by proteasomal degradation of a major antiviral IFN effector, the translation-inhibiting protein kinase PKR. Here, we identified components of the modular SCF (Skp1, Cul1, F-box protein)-type E3 ubiquitin ligases as mediators of PKR destruction by NSs. Small interfering RNAs (siRNAs) against the conserved SCF subunit Skp1 protected PKR from NSs-mediated degradation. Consequently, RVFV replication was severely reduced in Skp1-depleted cells when PKR was present. SCF complexes have a variable F-box protein subunit that determines substrate specificity for ubiquitination. We performed an siRNA screen for all (about 70) human F-box proteins and found FBXW11 to be involved in PKR degradation. The partial stabilization of PKR by FBXW11 depletion upregulated PKR autophosphorylation and phosphorylation of the PKR substrate eIF2α and caused a shutoff of host cell protein synthesis in RVFV-infected cells. To maximally protect PKR from the action of NSs, knockdown of structurally and functionally related FBXW1 (also known as β-TRCP1), in addition to FBXW11 deletion, was necessary. Consequently, NSs was found to interact with both FBXW11 and β-TRCP1. Thus, NSs eliminates the antiviral kinase PKR by recruitment of SCF-type E3 ubiquitin ligases containing FBXW11 and β-TRCP1 as substrate recognition subunits. This antagonism of PKR by NSs is essential for efficient RVFV replication in mammalian cells. IMPORTANCE: Rift Valley fever virus is a pathogen of humans and animals that has the potential to spread from Africa and the Arabian Peninsula to other regions. A major virulence mechanism is the proteasomal degradation of the antiviral kinase PKR by the viral protein NSs. Here, we demonstrate that NSs requires E3 ubiquitin ligase complexes of the SCF (Skp1, Cul1, F-box protein) type to destroy PKR. SCF-type complexes can engage variant ubiquitination substrate recognition subunits, and we found the F-box proteins FBXW11 and β-TRCP1 to be relevant for the action of NSs against PKR. Thus, we identified the host cell factors that are critically needed by Rift Valley fever virus to uphold its replication against the potent antiviral kinase PKR.

Indexed as

Animalsbeta-Transducin Repeat-Containing ProteinsCell LineChlorocebus aethiopsCullin ProteinseIF-2 KinaseF-Box ProteinsHumansRift Valley fever virusRNA, Small InterferingS-Phase Kinase-Associated ProteinsUbiquitin-Protein LigasesVero CellsViral Nonstructural ProteinsVirulence FactorsVirus Replicationbeta-Transducin Repeat-Containing ProteinsCullin 1Cullin ProteinseIF-2 KinaseF-Box ProteinsFBXW11 protein, humanRNA, Small InterferingSKP1 protein, humanS-Phase Kinase-Associated ProteinsUbiquitin-Protein LigasesViral Nonstructural ProteinsVirulence Factors

Identifiers

PMID27122577
PMCPMC4907219
OpenAlexW2342522707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.